Why Australian Pharmaceutical Industries Ltd (ASX:API) shares are up 8% today

Shares in Australian Pharmaceutical Industries Ltd (ASX: API), the health and beauty company which is partly owned by Washington H. Soul Pattinson and Co. Ltd (ASX: SOL), were up 8% today after the company announced a $127.4 million agreement to acquire the assets of Clearskincare Clinics.

The purchase price will be paid in installments over three years.

According to the announcement, API will initially acquire a 50.1% controlling stake and gradually increase this to 100% ownership by September 2021.

The transaction will be funded by debt facilities that have been established for the acquisition.

Clearskincare has 42 clinics in Australia and 2 in New Zealand which provide laser hair removal, skin treatments and cosmetic injectable services.

Impact on API’s earnings

API said that after accounting for interest costs on new debt facilities, it expects the impact of the acquisition to be earnings per share (EPS) positive in FY 19. This is based on Clearskincare clinics’ track record of growth and strong cash generation which is expected to continue going forward.

Benefits to API

In addition to being EPS accretive, management flagged a number of benefits for API in doing this deal including:

  • Marketing synergies given that Clearskincare and Priceline have a similar customer base
  • Diversification of revenue sources away from government funding
  • Well managed founder led business with an established market position

Foolish Takeaway

The full $127.4 million acquisition was made based on a valuation of 7.6 times EBITDA and the initial payment was based on a valuation 8.9 times FY 19’s forecast EBITDA.

This is a premium to the 6 times EBITDA that API itself trades at (assuming the second half of  FY 18 replicates the 1H18 EBITDA of $58.7 million).

That’s not cheap for a slow growing business but API has defensive qualities and strong consumer brands such as Priceline and Soul Pattinson. The Clearskincare acquisition will complement and diversify this suite of brands.

API has a 10-year dividend growth rate of 26% and looking forward, I expect that to continue as the company benefits from a growing and ageing population.

4 Stocks for Building Wealth After 50

Renowned investor Scott Phillips just released a brand-new report detailing his 4 favourite stocks to buy right now.

And I don’t know about you, but I always pay attention when some of the best investors in the world give me a stock tip.

This is your chance to get in at the very beginning of what could prove to be very special investments.

Click here to get started today!

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned.

You can find Kevin on Twitter @KevinGandiya.

The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!